Resident cardiac stem cells: how to find and use them
|
|
- Arnold Grant
- 5 years ago
- Views:
Transcription
1 Resident cardiac stem cells: how to find and use them G. Hasenfuß Cardiology and Pneumology Heart Research Center Göttingen Georg-August-University Göttingen
2 Definition: Stem cell Selfrenewal Stem cell Differentiation Proliferation Pluripotency: Potential for differentiation into all cells of the body
3 Bone marrow stem cells Bone marrow cells regenerate infarcted rat hearts C-kit +, lineage-negative EGFP mouse bone marrow cells in rat hearts 3-5h after infarction. 9 Days after injection myocytes and vascular cells: Transdifferentiation Orlic et al., Nature 2001
4 Lack of transdifferentiation of bone marrow cells into cardiomyocytes Bone-marrow-derived haematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation Nygren et al., Nat. Med 2004 Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Murry et al., Nature 2004 Haematopoietic stem cells adopt mature haematopoietic fates in ischemic myocardium Balsam et al., Nature 2004 After 6 weeks cell-treated mice showed a statistically significant, although modest, improvement of fractional shortening, and left ventricular dimensions
5 Cardiomyogenic stem cells mouse heart Blastocysts Brachyury Precursors Precardiac mesoderm Embryos MSP; Flk +/- RV, OT, RA, LA ES Cells EC Cells EG Cells Embryonic Heart Isl1; Nkx2.5; c-kit+ LV, RA, LA Cardiac progenitor cells Cardiac commitment Myocytes, VSNC, EC Neonatal Heart Adult Heart Sca 1 c-kit Side Population Cardiosphere L. Field
6 Cardiac stem cells in mice Green: c-kit pos White: NKx2,5 Blue: nuclei Red: -actin Sca1 cells: Oh et al. PNAS 2003 SP cells: Martin et al. Dev Biol 2004 ATP-binding cassette transporter ABCG2 Beltrami et al., Cell 2003
7 Human resident cardiac stem cells?
8 Human Cardiospheres from biopsies Atrial and ventricular biopsies during cardiac surgery Trypsin digestion, culture of tissue fragments for 1-3 weeks Adherent fibroblast-like cells migrating small, phase-bright cells c-kit + Cardiac Markers Collection of phase-bright cells (4x within 6-10 days) Passage of CSs every 2-3 days Immunofluorescence: ctni, ANP, MHC (external layers), CD34, C-kit, Sca1 and others (c-kit = BrdU incorporation) Messina et al., Circ Res 2004
9 Cardiosphere-derived cells from percutaneous endomyocardial biopsis RV endomyocardial biopsis from transplant and nontransplant patients 70 pts. 1.7± 0.4 x 10 6 CDCs per patient (in 69/70) C-kit, CD105, Ki67 (center), connexin43, α sarcomeric actin different from bone marrow derived C-kit + cells CDCs contain subpopulations with mesenchymal cells, fibroblasts No spontaneous contractions Co-culture to obtain beating cells Smith et al., Circulation 2007
10 Injection of CDCs in mouse heart Immunofluorescence after 20 days Improvement of function in infarcted hearts Smith et al., Circulation 2007
11 Autologous CDCs in Porcine ICM Endomyocardial biopsies from pigs Intracoronary infusion 4 weeks after MI CDCs versus placebo 94 % biopsy success (52.6 ± 6.7 mg) 91 % success of CDCs generation 24.5 ± 2.9 x 10 6 cells in 2.7 ± 0.1 passages and 26.9 ± 1.3 days Johnston et al., Circulation 2009
12 Infarct size after 8 weeks Johnston et al., Circulation 2009
13 Contractile function after 8 weeks Johnston et al., Circulation 2009
14 Cardiospheres open Questions Diffentiation into cardiomyocytes? Clinical studies are being performed Messina et al., Circ Res 2004
15 Human Cardiomyocyte progenitor cells (CMPCs) (Sca-1 based) LA Collagenase Smits et al., Nat Prot 2009
16 Cardiomyocyte progenitor cells (CMPCs) (Sca-1 based) Magnetic cell sorting: iron-labeled mouse Sca-1 AB [Sca-1 not expressed from human cells, however population of human cells is isolated, cross-reaction of AB with unknown protein] Rapid cell devision with 1 / day for 75 passages Differentiation into cardiomyocytes only with 5 Azacytidine (5 aza induces genome-wide demethylation) Smits et al., Nat Prot 2009
17 C-kit + human cardiac stem cells (hcscs) 1% c-kit + cadiac niches Myocardial biopsies Enzymatic digestion cell sorting with immunobeads based on c-kit-ab cell culture outgrow of c-kit + cells immunocytochemistry (3 weeks) sucess in 8 / 12 and 46 / 70 cases 1 % c-kit + cells Expression of myocyte markers no beating cardiomyocytes Injection of cells into mouse hearts with MI regeneration with new human myocytes and capillaries Bearzi et al., PNAS 2007
18 Myocardium control heart within 24h after death c-kit MDR1 Sca-1 Urbanek et al., PNAS 2003
19 Myocardium from outflow tract during valve replacement Urbanek et al., PNAS 2003
20 C-kit-positive cells Pouly et al., J Thor and CV Surgery 2007
21 C-kit-positive cells Pouly et al., J Thor and CV Surgery 2007
22 Cardiac stem cells in the real world 32 endomyocardial biopsies from heart transplant recipients 18 RA appendages 2.7 c-kit-positive cells / mm 2 in EM biopsies 1 c-kit-positive cell / mm 2 in RA tissue all c-kit-positive cells co-stained for CD45 and expressed tryptase as a specific mast cell marker no expression of stemness markers Pouly et al., J Thor and CV Surgery 2008
23 Summary No proof of cardiomyocyte differentiation of resident cardiac stem cells from human heart (without being brutal!) No convincing data against hypothesis that c-kit-positive cells are mast cells and that cardiospheres contain cardiomyocytes as carry over. Wait for clinical studies with cardiospheres
SUPPLEMENTARY INFORMATION
doi:10.1038/nature10188 Supplementary Figure 1. Embryonic epicardial genes are down-regulated from midgestation stages and barely detectable post-natally. Real time qrt-pcr revealed a significant down-regulation
More informationStem Cells. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford
Stem Cells Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford Adult Stem Cells Unique cells that are capable of self-renewal Have the ability to differentiate
More informationDOWNLOAD PDF CARDIAC REMODELING AND CELL DEATH IN HEART FAILURE
Chapter 1 : The fibrosis-cell death axis in heart failure Remodeling may be defined as changes in the morphology, structure, and function of the heart related to alterations in loading conditions and/or
More informationCell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction. Rita Alonaizan
Cell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction Rita Alonaizan Department of Physiology, Anatomy & Genetics St Catherine s College Supervisor:
More informationThe Jay Cohn Lecture 2012: Therapeutic regeneration of the injured heart
The Jay Cohn Lecture 2012: Therapeutic regeneration of the injured heart Eduardo Marbán, M.D., Ph.D. Director, Cedars-Sinai Heart Institute Los Angeles, CA Disclosure: founder & stockholder, Capricor Inc.
More informationCell Combination Therapy. Disclosures
Cell Combination Therapy Joshua M. Hare, M.D. Louis Lemberg Professor Senior Associate Dean Chief Science Officer Interdisciplinary Stem Cell Institute The Miller School of Medicine, University of Miami
More informationParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all
More informationSupporting Information. Calculation of the relative contributions of myocyte proliferation, stem cell. Supporting Information Fig 1 (page 9)
Supporting Information Table of contents Calculation of the relative contributions of myocyte proliferation, stem cell differentiation and cardioprotection (page 2) Supporting Information Fig 1 (page 9)
More informationDr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK
Advanced heart failure - devices, mechanical circulatory support and cardiac transplantation Monday 30 January 2017 Stem cell and gene therapies for heart failure Dr. Alexander Lyon Senior Lecturer and
More informationHeart Development. Robert G. Kelly Developmental Biology Institute of Marseilles - Luminy
ESC CBCS Summer School on Cardiovascular Sciences 15th June 2011 Heart Development Robert G. Kelly Developmental Biology Institute of Marseilles - Luminy Animal models of heart development Tinman/Nkx2.5
More informationMyocardial Regeneration and Stem Cell Repair
Myocardial Regeneration and Stem Cell Repair Annarosa Leri, MD, Jan Kajstura, MD, Piero Anversa, MD, and William H. Frishman, MD Abstract: Recent evidence would suggest that the heart is not a terminally
More informationHeart Development. Origins of congenital heart defects Properties of cardiac progenitor cells. Robert G. Kelly
ESC CBCS Summer School on Cardiovascular Sciences Heart Development 19th June 2013 Origins of congenital heart defects Properties of cardiac progenitor cells Robert G. Kelly Animal models of heart development
More informationTranslating Molecular Insights Into New Cellular Therapies For Cardiovascular Disease
Ottawa Hospital Research Institute Institute de recherche de l Hopital d Ottawa Translating Molecular Insights Into New Cellular Therapies For Cardiovascular Disease ACC Rockies March 11-14, 2012 Dr. Duncan
More informationRegenerative Medicine for Cardiomyocytes
Regenerative Medicine Regenerative Medicine for JMAJ 47(7): 328 332, 2004 Keiichi FUKUDA Assistant Professor, Institute for Advanced Cardiac Therapeutics, Keio University School of Medicine Abstract: Heart
More informationCell-based therapy for prevention and reversal of myocardial remodeling
Cell-based therapy for prevention and reversal of myocardial remodeling Vasileios Karantalis, Wayne Balkan, Ivonne H. Schulman, Konstantinos E. Hatzistergos and Joshua M. Hare Am J Physiol Heart Circ Physiol
More informationStem cells: units of development and regeneration. Fernando D. Camargo Ph.D. Whitehead Fellow Whitehead Institute for Biomedical Research.
Stem cells: units of development and regeneration Fernando D. Camargo Ph.D. Whitehead Fellow Whitehead Institute for Biomedical Research Concepts 1. Embryonic vs. adult stem cells 2. Hematopoietic stem
More information9/23/2017. Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota
Department of Biomedical Engineering, University of Minnesota http://saliterman.umn.edu/ Murphy, S. V., and A. Atala. "3d Bioprinting of Tissues and Organs." Nature Biotechnology 32, no. 8 (Aug 2014):
More informationENGINEERING THREE DIMENSIONAL CARDIOSPHERES FROM PLURIPOTENT STEM CELLS
ENGINEERING THREE DIMENSIONAL CARDIOSPHERES FROM PLURIPOTENT STEM CELLS A Thesis Presented to The Academic Faculty by Nicole Votaw In Partial Fulfillment of the Requirements for the Degree B.S. in Biomedical
More informationMyocardial infarction
NEW CARDIAC MARKERS AND CARDIAC REGENERATION Päivi Lakkisto, MD, PhD Specialist in Clinical Chemistry Clinical lecturer University of Helsinki and HUSLAB Minerva Institute for Medical Research Myocardial
More information1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism
Pathobiology of Heart Failure Molecular and Cellular Mechanism Jonathan Leor Neufeld Cardiac Research Institute Tel-Aviv University Sheba Medical Center, Tel-Hashomer שאלה 1 התא הנפוץ ביותר (75%~) בלב
More informationProgress in clinical applications of PSCs in The bench to bedside pathway
Progress in clinical applications of PSCs in 2017 The bench to bedside pathway Trounson A. et al. Nature Reviews Molecular Cell Biology 17, 194 200 (2016) doi:10.1038/nrm.2016.10 Knoepfler PS Adv Drug
More informationDevices are So Old School: The New World of Myocardial Regeneration
Devices are So Old School: The New World of Myocardial Regeneration Todd K. Rosengart, M.D. Professor and Chairman DeBakey-Bard Chair of Surgery Michael E. DeBakey Department of Surgery Professor, Texas
More informationThe concept of regenerative medicine using the body s
MINI-REVIEW: EXPERT OPINIONS Stem Cell Therapy in Perspective Bodo E. Strauer, MD; Ran Kornowski, MD The concept of regenerative medicine using the body s own stem cells and growth factors to repair tissues
More informationE. Cervio, P. Danieli, C. Ciuffreda, F. Pisano, M. Roccio, M. Gnecchi. The authors have no financial disclosures to declare
16 th ISCT Annual Meeting SOLUBLE FACTORS RELEASED BY HUMAN MESENCHYMAL STEM CELLS OF FETAL ORIGIN LEAD TO CARDIOMYOCYTE PROTECTION THROUGH THE INHIBITION OF PRO-APOPTOTIC SIGNALING E. Cervio, P. Danieli,
More informationStem Cell Therapy for Heart Disease Revisited: the Paracrine Paradigm
17 th ISCT Annual Meeting May 18-21, Rotterdam, The Netherlands Stem Cell Therapy for Heart Disease Revisited: the Paracrine Paradigm Massimiliano Gnecchi, MD, PhD Università degli studi di Pavia Fondazione
More informationInternational Graduate Research Programme in Cardiovascular Science
1 International Graduate Research Programme in Cardiovascular Science This work has been supported by the European Community s Sixth Framework Programme under grant agreement n LSHM-CT-2005-01883 EUGeneHeart.
More informationCardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart
OPEN ACCESS Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart Konstantinos Malliaras, Yiqiang Zhang, Jeffrey
More informationCardiovascular Stem Cell Therapy
Cardiovascular Stem Cell Therapy Jeffrey A Southard, MD Assistant Clinical Professor, Medicine Division of Cardiovascular Medicine May 20, 2011 Cardiovascular Disease Effects 81.1 million Americans More
More informationCardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells
Translational Cardiology Most Recent Points of View J. Cell. Mol. Med. Vol 14, No 5, 2010 pp. 1064-1070 Guest Editor: P. Doevendans Cardiomyocyte progenitor cell-derived exosomes stimulate migration of
More informationStem cells for cardiac repair
Stem cells for cardiac repair Master Thesis Christine van de Werken Cancer Genomics and Developmental Biology Stem cells for cardiac repair 19/12/2008 Master Thesis Christine van de Werken (0424919) Master
More informationDomenico D Amario MD, PhD Università Cattolica del Sacro Cuore Rome:
Domenico D Amario MD, PhD Università Cattolica del Sacro Cuore Rome: 31.01.2014 (Rosamund et al, Circulation 2007) Discharges in Thousands Hospital discharges for heart failure by sex (United States: 1979-2004).
More informationEffective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features Loretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al. Clin Cancer Res
More informationProbe. Hind III Q,!?R'!! /0!!!!D1"?R'! vector. Homologous recombination
Supple-Zhang Page 1 Wild-type locus Targeting construct Targeted allele Exon Exon3 Exon Probe P1 P P3 FRT FRT loxp loxp neo vector amh I Homologous recombination neo P1 P P3 FLPe recombination Q,!?R'!!
More informationCardiac Stem Cells and Mechanisms of Myocardial Regeneration
Physiol Rev 85: 1373 1416, 2005; doi:10.1152/physrev.00013.2005. Cardiac Stem Cells and Mechanisms of Myocardial Regeneration ANNAROSA LERI, JAN KAJSTURA, AND PIERO ANVERSA Cardiovascular Research Institute,
More informationResearch progress of adult stem cells and clinical applications
18 4 2006 8 Chinese Bulletin of Life Sciences Vol. 18, No. 4 Aug., 2006 1004-0374(2006)04-0328-05 100850 Q831 A Research progress of adult stem cells and clinical applications XI Jia-Fei, WANG Yun-Fang,
More informationMyocyte Derived Cardiac Spheroids for Post Infarct Cardiac Regeneration
Myocyte Derived Cardiac Spheroids for Post Infarct Cardiac Regeneration A Thesis Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE In partial fulfillment of the requirements for the Degree of
More informationENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM
ENDOGENOUS CARDIAC STEM CELLS IN THE REGENERATION OF ACUTE AND CHRONIC ISCHEMIC MYOCARDIUM Bernardo Nadal-Ginard, M.D., Ph.D. New York Medical College Angioplasty Summit 2004, Seoul 04/29/04 MYOCARDIAL
More informationNIH Public Access Author Manuscript Science. Author manuscript; available in PMC 2010 July 2.
NIH Public Access Author Manuscript Published in final edited form as: Science. 2009 October 16; 326(5951): 426 429. doi:10.1126/science.1177350. Generation of Functional Ventricular Heart Muscle from
More informationStem cell therapy aimed at restoring organ function,
The : Insights and Lessons From Clinical Trials Kartik S. Telukuntla, BS; Viky Y. Suncion, MD; Ivonne H. Schulman, MD; Joshua M. Hare, MD Stem cell therapy aimed at restoring organ function, notably myocardial
More informationProtocol. Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia
(20218) Medical Benefit Effective Date: 01/01/11 Next Review Date: 07/18 Preauthorization No Review Dates: 09/10, 07/11, 07/12, 07/13, 07/14, 07/15, 07/16, 07/17 This protocol considers this test or procedure
More informationReview. Mesenchymal Stem Cells: Biology, Pathophysiology, Translational Findings, and Therapeutic Implications for Cardiac Disease
Review This Review is part of a thematic series on Stem Cells, which includes the following articles: Stem Cells Review Series: An Introduction [Circ Res. 2011;109:907 909] Biomaterials to Enhance Stem
More informationReview Article Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora s Box
SAGE-Hindawi Access to Research Stem Cells International Volume 2011, Article ID 536758, 20 pages doi:10.4061/2011/536758 Review Article Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold
More informationMesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future
Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Cell Therapy 2014 Las Vegas, NV, USA Sulaiman Al-Hashmi, PhD Sultan Qaboos University Oman What are MSCs? Stem
More informationThe official electronic file of this thesis or dissertation is maintained by the University Libraries on behalf of The Graduate School at Stony Brook
Stony Brook University The official electronic file of this thesis or dissertation is maintained by the University Libraries on behalf of The Graduate School at Stony Brook University. Alll Rigghht tss
More informationClinical Applications of Stem Cell Therapy for Regenerating The Heart
SPECIAL ARTICLE Clinical Applications of Stem Cell Therapy for Regenerating The Heart Andreas Soejitno*, Desak M. Wihandani**, R.A. Tuty Kuswardhani*** * Faculty of Medicine, Udayana University. Jl. PB.
More informationImproving Cardiac Repair by Stem Cell Factor Post-Myocardial Infarction
Western University Scholarship@Western Electronic Thesis and Dissertation Repository April 2013 Improving Cardiac Repair by Stem Cell Factor Post-Myocardial Infarction Fuli Xiang The University of Western
More informationStem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function Axel Linke*, Patrick Müller*, Daria Nurzynska*, Claudia Casarsa*,
More informationCardiac Myocytes are Recruited by Bone Marrow-Derived Cells in Intact Murine Heart
Kobe J. Med. Sci., Vol. 48, No. 6, pp. 161-166, 2002 Cardiac Myocytes are Recruited by Bone Marrow-Derived Cells in Intact Murine Heart SEIMI SATOMI-KOBAYASHI 1, SEINOSUKE KAWASHIMA 1*, TSUYOSHI SAKODA
More informationSide Population cells possess a stem cell nature: cytoprotection, proliferation, and role of functional recovery in the murine heart
Side Population cells possess a stem cell nature: cytoprotection, proliferation, and role of functional recovery in the murine heart A THESIS SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY
More informationREVIEW Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells
(2002) 9, 648 652 2002 Nature Publishing Group All rights reserved 0969-7128/02 $25.00 www.nature.com/gt REVIEW Hematopoietic, vascular and cardiac fates of bone marrow-derived stem cells KK Hirschi 1
More informationTHESIS. ROMANIAN ACADEMY Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest
ROMANIAN ACADEMY Institute of Cellular Biology and Pathology Nicolae Simionescu, Bucharest THESIS Study of progenitor cells differentiation into cardiomyocytes in order to improve cardiac cellular transplant
More informationPregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration
Review series Pregenerative medicine: developmental paradigms in the biology of cardiovascular regeneration B. Alexander Yi, 1 Oliver Wernet, 1 and Kenneth R. Chien 1,2 1 Cardiovascular Research Center,
More informationHematopoiesis. - Process of generation of mature blood cells. - Daily turnover of blood cells (70 kg human)
Hematopoiesis - Process of generation of mature blood cells - Daily turnover of blood cells (70 kg human) 1,000,000,000,000 total cells 200,000,000,000 red blood cells 70,000,000,000 neutrophils Hematopoiesis
More informationUNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II FACOLTA DI MEDICINA E CHIRURGIA
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II FACOLTA DI MEDICINA E CHIRURGIA Dottorato di ricerca in MORFOLOGIA CLINICA E PATOLOGIA Dipartimento di Scienze Biomorfologiche e Funzionali Formation of Temporary
More informationHaematopoietic stem cells
Haematopoietic stem cells Neil P. Rodrigues, DPhil NIH Centre for Biomedical Research Excellence in Stem Cell Biology Boston University School of Medicine neil.rodrigues@imm.ox.ac.uk Haematopoiesis: An
More informationTISSUE-SPECIFIC PROGENITOR AND STEM CELLS
Tissue-Specific Progenitor and Stem Cells TISSUE-SPECIFIC PROGENITOR AND STEM CELLS Concise Review: Skeletal Muscle Stem Cells and Cardiac Lineage: Potential for Heart Repair NARMEEN HASSAN, a,* JASON
More informationMicroRNA as a Biological Drug and Recovery of Myocardial Infarction. Exosome
MicroRNA as a Biological Drug and Recovery of Myocardial Infarction Exosome Jianyi (Jay) Zhang, MD, PhD Professor of Medicine, of Engineering University of Alabama - Birmingham UAB 1 Rebuilding the Failing
More informationREGENERATIVE MEDICINE
REGENERATIVE MEDICINE Concise Review: Engineering Myocardial Tissue: The Convergence of Stem Cells Biology and Tissue Engineering Technology JAN WILLEM BUIKEMA, a,b,c PETER VAN DER MEER, d JOOST P.G. SLUIJTER,
More informationFollow-up of the CUPID Gene Therapy Trials
Follow-up of the CUPID Gene Therapy Trials Roger J. Hajjar, MD Icahn School of Medicine at Mount Sinai New York, NY Pathway to Heart Failure Injury / Damage Mature Dysfunctional Dying New Coronary Disease
More informationStimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction
Research Article Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction Konstantinos Malliaras, Ahmed Ibrahim, Eleni Tseliou, Weixin Liu, Baiming Sun, Ryan C Middleton,
More informationReview Article Therapeutic Application of Cardiac Stem Cells and Other Cell Types
BioMed Research International Volume 2013, Article ID 736815, 6 pages http://dx.doi.org/10.1155/2013/736815 Review Article Therapeutic Application of Cardiac Stem Cells and Other Cell Types Emiko Hayashi
More informationMedical Coverage Policy Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia
Medical Coverage Policy Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia EFFECTIVE DATE: 02 01 2017 POLICY LAST UPDATED: 02 20 2018 OVERVIEW Progenitor cell therapy describes
More informationUniversity of Milano-Bicocca School of medicine and faculty of science
University of Milano-Bicocca School of medicine and faculty of science Isolation, characterization and ex vivo amplification of heartderived c-kit progenitor cells for cellular therapy Coordinator: Prof.
More informationNIH Public Access Author Manuscript Circulation. Author manuscript; available in PMC 2011 January 19.
NIH Public Access Author Manuscript Published in final edited form as: Circulation. 2010 January 19; 121(2): 293. doi:10.1161/circulationaha.109.871905. INTRACORONARY ADMINISTRATION OF CARDIAC PROGENITOR
More informationReprogramming through micrornas Stefanie Dimmeler
Klinikum der Johann Wolfgang Goethe Universität Frankfurt am Main Reprogramming through micrornas Stefanie Dimmeler Conflict of interest: T2cure GmbH, Miragen Non-coding DNA & RNA and micrornas Human Genome
More informationEuropean Society of Cardiology Congress DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS
European Society of Cardiology Congress 28 Aug - 01 Sep 2009, Stockholm - Sweden DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS Massimiliano
More informationTherapeutic Potential of Human Umbilical Cord Derived Stem Cells in a Rat Myocardial Infarction Model
Therapeutic Potential of Human Umbilical Cord Derived Stem Cells in a Rat Myocardial Infarction Model Kai Hong Wu, MD, PhD,* Bin Zhou, PhD,* Cun Tao Yu, MD, Bin Cui, MD, Shi Hong Lu, BS, Zhong Chao Han,
More informationCardiac Gene Therapy: Beyond the Mouse. David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA
Cardiac Gene Therapy: Beyond the Mouse David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA Presenter Disclosure Information FINANCIAL DISCLOSURE: Equity: Osprey Medical Grants/Research
More informationIschaemic Preconditioning prevents the differentiation induced by ischaemia/reperfusion injury of rat cardiac fibroblast to myofibroblast
Ischaemic Preconditioning prevents the differentiation induced by ischaemia/reperfusion injury of rat cardiac fibroblast to myofibroblast Kartika Pertiwi1 and Lisa Chilton2 1: Biology Education Department,
More informationCardiac repair with thymosin 4 and cardiac reprogramming factors
Ann. N.Y. Acad. Sci. ISSN 0077-8923 ANNALS OF THE NEW YORK ACADEMY OF SCIENCES Issue: Thymosins in Health and Disease Cardiac repair with thymosin 4 and cardiac reprogramming factors Deepak Srivastava,
More informationCSP. Cardiopulmonary Support and Physiology
Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro Shinya Fukuhara, MD, a Shinji Tomita, MD, PhD, b Seiji Yamashiro, MD, MSc, c Takayuki
More informationExtending the time window of mammalian heart regeneration by thymosin beta 4
J. Cell. Mol. Med. Vol 18, No 12, 2014 pp. 2417-2424 Extending the time window of mammalian heart regeneration by thymosin beta 4 Liu Rui #, Nie Yu #, Lian Hong, He Feng, Han Chunyong, Meng Jian, Zheng
More informationHuman Pluripotent Stem Cell Cardiomyocyte Differentiation Kit (PSCCDK) Introduction Kit Components Cat. # # of vials Reagent Quantity Storage
Human Pluripotent Stem Cell Cardiomyocyte Differentiation Kit (PSCCDK) Catalog #5901 Introduction Human pluripotent stem cells (hpsc), including embryonic stem cells (ESC) and induced pluripotent stem
More informationRegeneration Gaps Observations on Stem Cells and Cardiac Repair
Journal of the American College of Cardiology Vol. 47, No. 9, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.02.002
More informationMultimodality Imaging in Cardiac Stem Cell Research
Multimodality Imaging in Cardiac Stem Cell Research IL SUK SOHN, MD, PhD Department of Cardiology Kyung Hee University Hospital at Gangdong Kyung Hee University School of Medicine, Seoul, Korea Stem Cell
More informationCardiovascular cell therapy: next step is a custom work?
Cardiovascular cell therapy: next step is a custom work? Giulio Pompilio MD PhD UNITA DI RICERCA CLINICA E PRECLINICA DI TERAPIA RIGENERATIVA CARDIOVASCOLARE CENTRO CARDIOLOGICO MONZINO IRRCS UNIVERSITA
More informationMesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years ( )
Singh et al. Stem Cell Research & Therapy (2016) 7:82 DOI 10.1186/s13287-016-0341-0 REVIEW Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010 2015) Aastha
More informationJournal of the American College of Cardiology Vol. 59, No. 10, by the American College of Cardiology Foundation ISSN /$36.
Journal of the American College of Cardiology Vol. 59, No. 10, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.11.029
More informationEffects of reference compounds on impedance signals from stem cellderived human cardiomyocytes
Effects of reference compounds on impedance signals from stem cellderived human cardiomyocytes Herbert M. Himmel, Safety Pharmacology, Bayer Pharma AG, Wuppertal, Germany SPS Webinar Cardiac Safety Testing
More informationReview Article Functional Multipotency of Stem Cells: What Do We Need from Them in the Heart?
Stem Cells International Volume 2012, Article ID 817364, 12 pages doi:10.1155/2012/817364 Review Article Functional Multipotency of Stem Cells: What Do We Need from Them in the Heart? Pablo DíezVillanueva,
More informationSupplementary Figure 1. Spatial distribution of LRP5 and β-catenin in intact cardiomyocytes. (a) and (b) Immunofluorescence staining of endogenous
Supplementary Figure 1. Spatial distribution of LRP5 and β-catenin in intact cardiomyocytes. (a) and (b) Immunofluorescence staining of endogenous LRP5 in intact adult mouse ventricular myocytes (AMVMs)
More informationc-kit Stem Cell Therapy of Ischemic Cardiomyopathy
American Heart Association Scientific Sessions American Heart Association Scientific Sessions c-kit Stem Cell Therapy of Ischemic Cardiomyopathy Roberto Bolli, M.D. Institute of Molecular Cardiology University
More informationIncreasing the Presence of Cell Cycle Markers in Adult Cardiac Myocytes for the Treatment of Myocardial Infarction
Project Number MQP-GRG-0804 Increasing the Presence of Cell Cycle Markers in Adult Cardiac Myocytes for the Treatment of Myocardial Infarction A Major Qualifying Project Report Submitted to the Faculty
More informationErythropoietin preserves the endothelial differentiation potential of cardiac progenitor cells and attenuates heart failure during anti-cancer therapy
Erythropoietin preserves the endothelial differentiation potential of cardiac progenitor cells and attenuates heart failure during anti-cancer therapy Melanie Hoch Cardiology & Angiology MHH, Hannover
More informationCitation for published version (APA): Velde, S. V. D. (2006). Stem cell-mediated regeneration of the infarcted heart: inflammation rules? s.n.
University of Groningen Stem cell-mediated regeneration of the infarcted heart Velde, Susanne van der IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to
More informationCell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory
Cell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory BANFF-SCT Joint Scientific Meeting 2017 Barcelona, 29 th March Santi Roura, PhD Grup ICREC IGTP HuGTiP (Badalona)
More informationMyocyte turnover occurs in the human heart, and myocyte
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy Konrad Urbanek*, Federico Quaini*, Giordano Tasca, Daniele Torella*, Clotilde Castaldo*, Bernardo Nadal-Ginard*, Annarosa
More informationInduced Pluripotent Stem Cells: an Introduction Oren Caspi MD, PhD
Induced Pluripotent : an Introduction Oren Caspi MD, PhD The Sohnis laboratory for cardiac electrophysiology and regenerative medicine The Bruce Rappaport Faculty of Medicine, Technion - Israel Institute
More informationSignificant Improvement of Heart Function by Cotransplantation of Human Mesenchymal Stem Cells and Fetal Cardiomyocytes in Postinfarcted Pigs
Significant Improvement of Heart Function by Cotransplantation of Human Mesenchymal Stem Cells and Fetal Cardiomyocytes in Postinfarcted Pigs Jiang-Yong Min, MD, Matthew F. Sullivan, BS, Yinke Yang, MD,
More informationStem Cells as a therapy for myocardial infarction in animal models
Alma Mater Studiorum Università degli Studi di Bologna Tesi di Dottorato: Stem Cells as a therapy for myocardial infarction in animal models Dottorato di Ricerca in Biochimica XX ciclo Settore scientifico
More informationReviews. This Review is part of a thematic series on Cellular Therapy, which includes the following articles:
Reviews This Review is part of a thematic series on Cellular Therapy, which includes the following articles: The Stem Cell Movement Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy
More informationIN THE UNITED STATES PATENT AND TRADEMARK OFFICE
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In the matter of: Reexamination Control. No. 95/000,154 Art Unit: 3991 U.S. Patent No. 7,029,913 Issued: April 18, 2006 Examiner: Gary L. Kunz Inventor:
More informationExercise in Adverse Cardiac Remodeling: of Mice and Men
Exercise in Adverse Cardiac Remodeling: of Mice and Men 17-01-2013 Dirk J Duncker Experimental Cardiology, Cardiology, Thoraxcenter Cardiovascular Research Institute COEUR Erasmus MC, University Medical
More informationFOCUS ON CARDIOVASCULAR DISEASE
The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.
More informationE10.5 E18.5 P2 10w 83w NF1 HF1. Sham ISO. Bmi1. H3K9me3. Lung weight (g)
Myociyte cross-sectional Relative mrna levels Relative levels Relative mrna levels Supplementary Figures and Legends a 8 6 4 2 Ezh2 E1.5 E18.5 P2 1w 83w b Ezh2 p16 amhc b-actin P2 43w kd 37 86 16 wt mouse
More informationReview. Current perspective of stem cell therapies for cardiac regeneration. Yee Ki Lee 1, Chung-Wah Siu 1,2, Yang Zhang 1 & Hung-Fat Tse 1,2
Review Current perspective of stem cell therapies for cardiac regeneration Despite recent advances in prevention and treatment of coronary artery disease, it remains the major cause of morbidity and mortality
More informationMuscle Stem Cells in Regeneration
Muscle Stem Cells in Regeneration Dr. F Jeffrey Dilworth BIM6028/SMC6052 Lecture (February 11, 2016) Duchenne Muscular Dystrophy is an X-linked genetic disorder that affects 1 in 3500 males Wells et al,
More informationReview. This Review is part of a thematic series on Stem Cells, which includes the following articles:
Review This Review is part of a thematic series on Stem Cells, which includes the following articles: Differentiation of Pluripotent Embryonic Stem Cells Into Cardiomyocytes Neural Stem Cells: An Overview
More informationReview Article Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy
BioMed Volume 2013, Article ID 583912, 6 pages http://dx.doi.org/10.1155/2013/583912 Review Article Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy Yoshiki Sawa and
More informationHeart Regeneration: More Hope, Less Hype
Heart Regeneration: More Hope, Less Hype Hesham A. Sadek MD, PhD February 26 2016 Internal Medicine Grand Rounds University of Texas Southwestern Medical Center This is to acknowledge that Hesham Sadek
More information